Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
-2.68%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$39B
AUM Growth
-$220M
(-0.56%)
Cap. Flow
+$1.45B
Cap. Flow
% of AUM
3.7%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,663
New
306
Increased
844
Reduced
1,189
Closed
301
Top Buys
| 1 |
Microsoft
MSFT
|
+$566M |
| 2 |
Tesla
TSLA
|
+$479M |
| 3 |
Amazon
AMZN
|
+$449M |
| 4 |
Advanced Micro Devices
AMD
|
+$388M |
| 5 |
Qualcomm
QCOM
|
+$343M |
Top Sells
| 1 |
Charles Schwab
SCHW
|
+$357M |
| 2 |
Union Pacific
UNP
|
+$340M |
| 3 |
Walmart
WMT
|
+$239M |
| 4 |
Citigroup
C
|
+$180M |
| 5 |
ConocoPhillips
COP
|
+$178M |
Sector Composition
| 1 | Technology | 24.96% |
| 2 | Healthcare | 15.25% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Industrials | 10.41% |
| 5 | Financials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Gold Royalty Corp
GROY
$642M
| $67.5K | ﹤0.01% |
52,700
-8,700
| -14% | -$11.1K |
|
2252
Generation Bio
GBIO
$41.4M
| $67.1K | ﹤0.01% |
1,770
-980
| -36% | -$37.1K |
|
2253
Caribou Biosciences
CRBU
$171M
| $66.9K | ﹤0.01% |
+14,000
| New | +$66.9K |
|
|
CBD
2254
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $64.5K | ﹤0.01% |
96,700
-270,200
| -74% | -$180K |
|
|
DOYU
2255
DouYu International Holdings
DOYU
$241M
| $64.2K | ﹤0.01% |
6,590
-3,060
| -32% | -$29.8K |
|
|
SOL
2256
Emeren Group
SOL
$96.5M
| $64.1K | ﹤0.01% |
+20,800
| New | +$64.1K |
|
2257
Sundial Growers
SNDL
$623M
| $63.5K | ﹤0.01% |
+33,400
| New | +$63.5K |
|
2258
Gaia
GAIA
$140M
| $63.1K | ﹤0.01% |
23,200
-200
| -0.9% | -$544 |
|
2259
Cantaloupe
CTLP
$792M
| $62.5K | ﹤0.01% |
+10,000
| New | +$62.5K |
|
2260
LG Display
LPL
$4.39B
| $62.5K | ﹤0.01% |
12,800
| – | – |
|
2261
VirnetX
VHC
$76.3M
| $62.3K | ﹤0.01% |
12,251
+5,730
| +88% | +$29.1K |
|
2262
Vuzix
VUZI
$178M
| $61.7K | ﹤0.01% |
17,000
-7,700
| -31% | -$28K |
|
|
AUTL
2263
Autolus Therapeutics
AUTL
$365M
| $58.5K | ﹤0.01% |
25,100
-1,300
| -5% | -$3.03K |
|
2264
Edgewise Therapeutics
EWTX
$1.55B
| $58.4K | ﹤0.01% |
+10,200
| New | +$58.4K |
|
2265
Standard BioTools
LAB
$489M
| $57.7K | ﹤0.01% |
19,900
-10,200
| -34% | -$29.6K |
|
2266
OmniAb
OABI
$226M
| $57.4K | ﹤0.01% |
11,050
-4,000
| -27% | -$20.8K |
|
2267
Cardiff Oncology
CRDF
$142M
| $57K | ﹤0.01% |
41,000
-131,800
| -76% | -$183K |
|
2268
Alaunos Therapeutics
TCRT
$5.07M
| $56.8K | ﹤0.01% |
2,875
-1,380
| -32% | -$27.3K |
|
2269
ALX Oncology
ALXO
$58.4M
| $55.7K | ﹤0.01% |
11,600
-34,600
| -75% | -$166K |
|
2270
Clearside Biomedical
CLSD
$26.6M
| $54.7K | ﹤0.01% |
62,900
-37,200
| -37% | -$32.4K |
|
2271
Stoke Therapeutics
STOK
$1.21B
| $54.4K | ﹤0.01% |
+13,800
| New | +$54.4K |
|
2272
GrowGeneration
GRWG
$92.6M
| $53.7K | ﹤0.01% |
18,400
+1,500
| +9% | +$4.38K |
|
2273
Cidara Therapeutics
CDTX
$1.6B
| $52K | ﹤0.01% |
2,760
-1,070
| -28% | -$20.2K |
|
|
ELEV
2274
DELISTED
Elevation Oncology
ELEV
| $50.9K | ﹤0.01% |
+76,800
| New | +$50.9K |
|
2275
Inotiv
NOTV
$55.3M
| $50.5K | ﹤0.01% |
16,400
+3,300
| +25% | +$10.2K |
|